MURAL ONCOLOGY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.58 USD | -0.28% |
|
-5.04% | -39.53% |
| 04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
| 01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 3.920 | 6.010 | 5.920 |
| Spread/Res. | -8.67% | -40.43% | -39.53% |
| Spread/Supp. | +1.42% | +8.81% | +4.37% |
| Support | 3.530 | 3.290 | 3.430 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MURA Stock
- Charts Mural Oncology plc
